Provided by Tiger Fintech (Singapore) Pte. Ltd.

CRISPR Therapeutics AG

37.82
+0.05000.13%
Pre-market: 38.630.8100+2.14%05:36 EDT
Volume:1.65M
Turnover:62.96M
Market Cap:3.24B
PE:-8.71
High:39.27
Open:37.06
Low:36.66
Close:37.77
Loading ...

Shareholders in CRISPR Therapeutics (NASDAQ:CRSP) are in the red if they invested a year ago

Simply Wall St.
·
06 Mar

AI Biotech Stocks Shined, With Ginkgo Up 8%, Recursion And Absci Up 4%, Crispr Up 3%

Tiger Newspress
·
05 Mar

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
05 Mar

Top Executive Makes Bold Move with Major Stock Purchase!

TIPRANKS
·
01 Mar

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.

Motley Fool
·
28 Feb

Intellia Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Company Progress

GlobeNewswire
·
27 Feb

AI Biotech Stocks Tumbled, with HIMS Plunging 17% and TEM Slumping 15%

Tiger Newspress
·
25 Feb

Illumina transforms multiomic research with new technologies to unlock deeper understanding of biology

PR Newswire
·
24 Feb

Editas Medicine to Announce Fourth Quarter/Full Year 2024 Financial Results and to Participate in Investor Conferences in March

GlobeNewswire
·
24 Feb

2 Beaten-Down Stocks to Buy Before They Soar by 66% and 415%, According to Wall Street

Motley Fool
·
24 Feb

CRISPR Therapeutics AG (CRSP): the Most Oversold Pharma Stock to Buy According to Analysts

Insider Monkey
·
24 Feb

Crispr Therapeutics Is Maintained at Buy by Citigroup

Dow Jones
·
19 Feb

CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?

Zacks
·
18 Feb

24H | Chinese ADRs and ETFs Extended Gains; YINN up 6%; XPeng, Alibaba up 5%; Li Auto up 4%; PDD Holdings up 2%; NIO up 1%

Tiger Newspress
·
18 Feb

Street Calls of the Week

Investing.com
·
16 Feb

Why CRISPR Therapeutics (CRSP) Soared on Friday?

Insider Monkey
·
15 Feb

Catherine Wood's Strategic Adjustment in CRISPR Therapeutics AG Holdings

GuruFocus
·
15 Feb

CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99

GuruFocus
·
15 Feb

CRISPR Therapeutics Stock Upgrade Following Analyst Reassessment

GuruFocus
·
14 Feb

Medical AI Stocks Soar; CRISPR Rises 16%; Recursion Pharma Jumps 14%; Tempus AI up 5%

Tiger Newspress
·
14 Feb